StockWatch
·
HomeLiveReports
Biotechnology: Pharmaceutical Preparations
AGM/EGMMay 19, 2026, 04:13 PM

Decoy Therapeutics Sets 2026 Annual Meeting for July 14

AI Summary

Decoy Therapeutics Inc. announced its 2026 Annual Meeting of Stockholders will be held on July 14, 2026. Stockholders of record as of May 22, 2026, will be eligible to vote. Due to a change in the meeting date by more than 30 days, new deadlines for shareholder proposals and director nominations have been established, all set for May 29, 2026.

Key Highlights

  • 2026 Annual Meeting of Stockholders scheduled for July 14, 2026.
  • Record date for voting eligibility is May 22, 2026.
  • Meeting date changed by over 30 days from last annual meeting anniversary.
  • Deadline for Rule 14a-8 shareholder proposals is May 29, 2026.
  • Deadline for advance notice director nominations is May 29, 2026.
  • Deadline for universal proxy rule 14a-19 notice is May 29, 2026.
View SEC Filing
DCOY
Biotechnology: Pharmaceutical Preparations
Decoy Therapeutics Inc.

Price Impact

More from DCOY

Quarterly ResultAug 12, 4:16 PM

Decoy Therapeutics Reports Increased Net Loss, Going Concern Doubt

Corporate ActionAug 4, 5:03 PM

Decoy Therapeutics to vote on warrant exercise, authorized share reduction

Corporate ActionJul 10, 4:31 PM

Decoy Therapeutics Registers 3.77M Shares for Resale

More in AGM/EGM

VSAT1d ago, 5:27 PM

Viasat Inc. Elects Directors, Ratifies Auditor at Annual Meeting

KSCP1d ago, 5:06 PM

Knightscope Stockholders Approve Equity Plan Amendment, Elect Directors

INEO1d ago, 4:14 PM

INNEOVA Holdings Ltd Approves Share Consolidation at AGM; Re-elects Directors, Auditor Ratified